News
SmithKline Beecham fined in Hungary
BMJ 1997; 315 doi: https://doi.org/10.1136/bmj.315.7120.1397l (Published 29 November 1997) Cite this as: BMJ 1997;315:1397
- Carl Kovac
- Budapest
SmithKline Beecham Pharmaceuticals has been fined one million Hungarian florints (£3065) by the Hungarian Consumer Protection Authority and ordered to withdraw advertisements that promote vaccinations against hepatitis B.
The advertisements started appearing in August in magazines targeted at teenagers and on television. According to the national public health commissioner, Ilona Molnár, the advertisements exaggerated the …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.